NioCorp Secures Non-Binding Offtake and Eyes $800M EXIM Loan, But Financing Cliff Remains

What happened

NioCorp Developments announced a 10-year non-binding offtake agreement with Traxys for its Elk Creek project, covering a broad range of planned products and validating the sales channel. The company also highlighted an active $800 million EXIM Bank debt application and a cash position of $419 million, which the bull case uses to justify a Strong Buy rating. However, the offtake remains non-binding, and the former Yorkville equity facility expired on April 1, 2026, leaving no committed replacement financing. The $1.2 billion Elk Creek capex still requires a fully committed capital stack, and EXIM diligence is ongoing with no assurance of final approval. Portal construction has started, but cost overruns or schedule delays could accelerate dilution if EXIM falls through.

Implication

For investors, the offtake agreement reduces some revenue uncertainty but does not eliminate the need for committed capital to bridge the gap left by the expired Yorkville facility. The $800 million EXIM loan is a potential game-changer, but its approval is not guaranteed and could take months. Portal construction provides a tangible execution milestone, but cost overruns would eat into the $419 million cash buffer. The stock's current price of ~$6.20 already prices in significant progress toward financing; failure to secure a committed facility by mid-2026 would likely trigger a re-rating lower. Until definitive offtake contracts and a binding debt commitment are secured, the risk/reward is skewed to the downside.

Thesis delta

The thesis shifts from a pure equity-dilution story to one where partial offtake coverage reduces revenue risk but does not resolve the near-term financing cliff. The key variable is now whether NioCorp can convert non-binding offtake into definitive contracts quickly enough to satisfy EXIM diligence and replace the expired Yorkville facility. Without that, the bear case of repeated discounted equity raises remains the higher-probability outcome.